Spectrum of CFTR gene mutations in Iranian Azeri Turkish patients with cystic fibrosis

Author(s): Bonyadi M, Omrani O, Rafeey M, Bilan N

Abstract

Aims: Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. In the present study, for the first time, we determined the spectrum of CFTR gene mutations in 100 patients with CF originated from the Iranian Azeri Turkish ethnic group.

Results: Here, we report identification of 17 previously known and one novel mutation, namely K1302X, in this cohort. The frequency of deltaF508 mutation was found to be 23%.

Conclusions: Low frequency of deltaF508 mutation and detection of one novel and 16 known mutations reflect a heterogeneous spectrum of the mutations in this ethnic group.

Similar Articles

The diminishing trend of β-thalassemia in Southern Iran from 1997 to 2011: the impact of preventive strategies

Author(s): Joulaei H, Shahbazi M, Nazemzadegan B, Rastgar M, Hadibarhaghtalab M, et al.

Fourteen-year experience of prenatal diagnosis of thalassemia in Iran

Author(s): Najmabadi H, Ghamari A, Sahebjam F, Kariminejad R, Hadavi V, et al.

Thalassemia in Iran: epidemiology, prevention, and management

Author(s): Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, et al.

Elucidating the spectrum of alpha-thalassemia mutations in Iran

Author(s): Hadavi V, Taromchi AH, Malekpour M, Gholami B, Law HY, et al.

HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server

Author(s): Hardison RC, Chui DH, Giardine B, Riemer C, Patrinos GP, et al.

Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem

Author(s): Boudrahem-Addour N, Zidani N, Carion N, Labie D, Belhani M, et al.

Use of haplotype analysis in the beta-globin gene cluster to discover beta-thalassemia mutations

Author(s): Kazazian HH Jr, Antonarakis SE, Cheng T, Boehm CD, Waber PG

Quantification of the close association between DNA haplotypes and specific beta-thalassaemia mutations in Mediterraneans

Author(s): Kazazian HH Jr, Orkin SH, Markham AF, Chapman CR, Youssoufian H, et al.

Molecular diagnostics for haemoglobinopathies

Author(s): Old J, Henderson S

Molecular characterization of β-thalassemia intermedia: a report from Iran

Author(s): Arab A, Karimipoor M, Rajabi A, Hamid M, Arjmandi S, et al.

The beta-thalassemia mutation spectrum in the Iranian population

Author(s): Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, et al.

Haplotype analysis of beta thalassemia patients in Western Iran

Author(s): Rahimi Z, Muniz A, Akramipour R, Tofieghzadeh F, Mozafari H, et al.

DNA polymorphism and molecular pathology of the human globin gene clusters

Author(s): Antonarakis SE, Kazazian HH Jr, Orkin SH

Genetic heterogeneity of Beta thalassemia in Lebanon reflects historic and recent population migration

Author(s): Makhoul NJ, Wells RS, Kaspar H, Shbaklo H, Taher A, et al.

beta-globin gene cluster haplotypes associated with beta-thalassemia on Corsica island

Author(s): Falchi A, Giovannoni L, Vacca L, Latini V, Vona G, et al.

Novel and Mediterranean beta thalassemia mutations in the indigenous Northern Ireland population

Author(s): Knott M, Ramadan KM, Savage G, Jones FG, El-Agnaf M, et al.